Evelyn S. Dilsaver

Sits on 4 boards. Last updated September 28, 2026

Time on boards

Boards served
4
Current seats
4
Board service
13 years
Director since
2023

13 years of board service in total across 4 boards, counting each seat separately. Longest: QuidelOrtho Corporation, 3 years.

3 years · Since 2023
3 years · Since 2023
3 years · Since 2023
PACS Group Inc. Director
2 years · Since 2024

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jul 1, 2026 PACS Group Inc. Grant or award +4,287 — —
Jun 25, 2026 HealthEquity Inc. Grant or award +2,877 — —
Jun 10, 2026 PACS Group Inc. Grant or award +4,660 — —
May 29, 2026 QuidelOrtho Corporation Grant or award +6,829 — —
May 13, 2026 Somnigroup International Inc. Grant or award +2,657 — —
Dec 19, 2025 PACS Group Inc. Grant or award +4,399 — —
Nov 24, 2025 PACS Group Inc. Open-market purchase +16,724 $29.90 $500,048
Sep 5, 2025 HealthEquity Inc. Option exercise +15,000 $21.27 $319,050
Sep 5, 2025 HealthEquity Inc. Open-market sale −3,461 $93.30 $322,911
Jun 26, 2025 HealthEquity Inc. Grant or award +2,003 — —
May 24, 2025 QuidelOrtho Corporation Grant or award +402 — —
May 24, 2025 QuidelOrtho Corporation Grant or award +80 — —
May 22, 2025 QuidelOrtho Corporation Grant or award +4,929 — —
May 14, 2025 Somnigroup International Inc. Grant or award +2,337 — —
Mar 6, 2025 Somnigroup International Inc. Option exercise +6,612 $14.96 $98,916

Questions about Evelyn S. Dilsaver

What boards is Evelyn S. Dilsaver on?

Evelyn S. Dilsaver sits on the boards of HealthEquity Inc., PACS Group Inc., QuidelOrtho Corporation and Somnigroup International Inc.

How long has Evelyn S. Dilsaver served on boards?

Our records show at least 13 years of board service across 4 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.